DrugPatentWatch Database Preview
BLINCYTO Drug Profile
Email this page to a colleague
Summary for Tradename: BLINCYTO
| Patents: | 27 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for BLINCYTO |
Recent Clinical Trials for BLINCYTO
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Medical College of Wisconsin | Phase 2 |
| University of Wisconsin, Madison | Phase 2 |
| Cardiff University | Phase 2 |
Company Disclosures: US Patents for BLINCYTO
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | BLINCYTO | blinatumomab | INJECTABLE;INJECTION | 125557 | 001 | 2014-12-03 | Get Started Free | Micromet AG (Munich, DE) | 2018-04-21 | RX | Orphan | company |
| Amgen | BLINCYTO | blinatumomab | INJECTABLE;INJECTION | 125557 | 001 | 2014-12-03 | Get Started Free | Micromet AG (Munich, DE) | 2018-04-21 | RX | Orphan | company |
| Amgen | BLINCYTO | blinatumomab | INJECTABLE;INJECTION | 125557 | 001 | 2014-12-03 | Get Started Free | Micromet AG (Munich, DE) | 2025-12-16 | RX | Orphan | company |
| Amgen | BLINCYTO | blinatumomab | INJECTABLE;INJECTION | 125557 | 001 | 2014-12-03 | Get Started Free | Micromet AG (Munich, DE) | 2029-10-27 | RX | Orphan | company |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for BLINCYTO
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | BLINCYTO | blinatumomab | INJECTABLE;INJECTION | 125557 | 001 | 2014-12-03 | Get Started Free | AbbVie Stemcentrx LLC (North Chicago, IL) | 2033-02-08 | RX | Orphan | search |
| Amgen | BLINCYTO | blinatumomab | INJECTABLE;INJECTION | 125557 | 001 | 2014-12-03 | Get Started Free | Advenchen Pharmaceuticals, LLC (Moorpark, CA) | 2035-05-04 | RX | Orphan | search |
| Amgen | BLINCYTO | blinatumomab | INJECTABLE;INJECTION | 125557 | 001 | 2014-12-03 | Get Started Free | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | Orphan | search |
| Amgen | BLINCYTO | blinatumomab | INJECTABLE;INJECTION | 125557 | 001 | 2014-12-03 | Get Started Free | Cipla Limited (Mumbai, IN) | 2036-06-30 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for BLINCYTO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2016222887 | Get Started Free |
| Mexico | 359953 | Get Started Free |
| Australia | 2019200841 | Get Started Free |
| China | 109906227 | Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
